Why Allucent?
Anchored by deep expertise and a high-touch partnership model, Allucent delivers operational excellence geared toward Neurology and Psychiatry drug development.
Testimonial
Preclinical planning to post-marketing success
We support your neurology and psychiatry drug development journey at every stage

- Pre-clinical, CMC, and Non-Clinical
- Gap/Risk Analysis
- Target Product Profile & Indication
- Global Regulatory Strategy, Translational Strategy & Modeling

- Protocol Design & Dose Optimization
- Phase I-III Clinical Trials
- Model Informed Drug Development
- CTD Authoring & Submissions

- Phase IV Clinical Studies
- Registration & Regulatory Compliance
- Pharmacovigilance & Medical Information
- Life Cycle Maintenance
Meet Some of Our Neurology & Psychiatry Drug Development Experts

About Us
A Fully Integrated Global Company
Allucent delivers innovative strategies and robust solutions based on over 30 years of background in regulatory trends, therapeutic experience, and operational expertise. We share small and mid-sized companies’ deep commitment to supporting breakthrough science by partnering with them to navigate the complexities of delivering novel treatments to patients.
With offices across North America, Europe, and the Middle East, Allucent has experience conducting trials in more than 75 countries, focusing on some of the most complex development areas. Globally, Allucent has worked on more than 825 clinical trials, with oncology representing the majority.
